
TY  - JOUR
TI  - Poster Sessions (PS)
JO  - European Journal of Biochemistry
VL  - 270
IS  - s1
SN  - 0014-2956
UR  - https://doi.org/10.1046/j.1432-1033.270.s1.8.x
DO  - doi:10.1046/j.1432-1033.270.s1.8.x
SP  - 32
EP  - 235
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts of the 58th Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis June 27 – 30, 2012
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 11
IS  - s3
SN  - 1538-7933
UR  - https://doi.org/10.1111/jth.12443
DO  - doi:10.1111/jth.12443
SP  - 1
EP  - 105
PY  - 2013
ER  - 

TY  - JOUR
AU  - Blackburn, Daniel
AU  - Sargsyan, Siranush
AU  - Monk, Peter N.
AU  - Shaw, Pamela J.
TI  - Astrocyte function and role in motor neuron disease: A future therapeutic target?
JO  - Glia
JA  - Glia
VL  - 57
IS  - 12
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.20848
DO  - doi:10.1002/glia.20848
SP  - 1251
EP  - 1264
KW  - astrocytes
KW  - astrogliosis
KW  - glial fibrillary acidic protein (GFAP)
KW  - motor neuron disease (MND)
PY  - 2009
AB  - Abstract Astrocytes are the most numerous cell type within the central nervous system (CNS) and perform a variety of tasks, from axon guidance and synaptic support, to the control of the blood brain barrier and blood flow. To perform these roles, there is a great variety of astrocytes. In this review, we summarize the function of astrocytes, in particular, their role in maintaining homeostasis at the synapse, regulating neuronal signaling, protecting neurons from oxidative damage, and determining the fate of endogenous neural precursors. The review also highlights recent developments indicating the role of astrocytes in motor neuron disease (MND), emphasizing their potential as therapeutic targets and agents in cell replacement therapy. The Cu-Zn superoxide dismutase (SOD1) gene that has been implicated in 20% of cases of familial MND must be expressed in the glial cells as well as motor neurons to produce the disease state in murine models of disease. Selectively reducing mutant SOD1 (mSOD1) in astrocytes does not affect disease onset but slows disease progression, whereas reducing mSOD1 in motor neurons delays disease onset and slows early disease but has less effect on life span. This suggests that glial cells represent potential therapeutic targets in MND. However, the lack of specific markers for astrocytes, their precursors, and sub-types means that our knowledge of astrocyte development/differentiation and response to injury lags far behind our understanding of function. Only by filling this knowledge gap can astrocytes be effectively targeted or replaced to successfully treat chronic CNS disorders such as MND. ? 2009 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - POSTERS
JO  - Journal of Anatomy
VL  - 212
IS  - 1
SN  - 0021-8782
UR  - https://doi.org/10.1111/j.1469-7580.2007.831_2.x
DO  - doi:10.1111/j.1469-7580.2007.831_2.x
SP  - 80
EP  - 96
PY  - 2008
ER  - 

TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650221407
DO  - doi:10.1002/jbmr.5650221407
SP  - s252
EP  - s301
PY  - 2007
ER  - 

TY  - JOUR
TI  - 144th Annual Meeting American Neurological Association
JO  - Annals of Neurology
JA  - Ann Neurol
VL  - 86
IS  - S24
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.25587
DO  - doi:10.1002/ana.25587
SP  - S1
EP  - S285
PY  - 2019
ER  - 

TY  - JOUR
TI  - The 14th Annual Meeting 2008 Japan Society of Gene Therapy
JO  - The Journal of Gene Medicine
JA  - J. Gene Med.
VL  - 11
IS  - 12
SN  - 1099-498X
UR  - https://doi.org/10.1002/jgm.1400
DO  - doi:10.1002/jgm.1400
SP  - 1138
EP  - 1193
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 125
IS  - S2
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.13297
DO  - doi:10.1111/bcpt.13297
SP  - 3
EP  - 330
PY  - 2019
ER  - 

TY  - JOUR
TI  - Miscellaneous B
JO  - Clinical & Experimental Ophthalmology
VL  - 36
IS  - s1
SN  - 1442-6404
UR  - https://doi.org/10.1111/j.1442-9071.2008.01781.x
DO  - doi:10.1111/j.1442-9071.2008.01781.x
SP  - A611
EP  - A635
PY  - 2008
ER  - 

TY  - JOUR
AU  - Baghaei, Kaveh
AU  - Tokhanbigli, Samaneh
AU  - Asadzadeh, Hamid
AU  - Nmaki, Saeed
AU  - Reza Zali, Mohammad
AU  - Hashemi, Seyed Mahmoud
TI  - Exosomes as a novel cell-free therapeutic approach in gastrointestinal diseases
JO  - Journal of Cellular Physiology
JA  - J Cell Physiol
VL  - 234
IS  - 7
SN  - 0021-9541
UR  - https://doi.org/10.1002/jcp.27934
DO  - doi:10.1002/jcp.27934
SP  - 9910
EP  - 9926
KW  - extracellular vesicles
KW  - gastrointestinal diseases
KW  - immune cell-derived exosomes
KW  - stem cell-derived exosomes
PY  - 2019
AB  - Abstract Cell communication through extracellular vesicles (EVs) has been defined for many years and it is not limited only to neighboring cells, but also distant ones in organisms receive these signals. These vesicles are secreted from the variety of cells and are composed of a distinctive component such as proteins, lipids, and nucleic acids. EVs have different classified subgroups regarding their cell origin, in this context, exosomes are the most appealing particles in cell biology, especially clinical in recent years and are represented as novel therapeutic agents with numerous advantages alongside and/or over cell therapy. However, cell therapy had a hopeful outcome in gastrointestinal diseases which have minimal alternatives in their treatments. Inflammatory bowel disease (IBD), liver fibrosis, gastrointestinal cancers are the examples that cell therapy and immunotherapy were applied in their treatment, therefore, the cell products like exosomes are the beneficial option in their treatment even cancers with promising results in animal models. In this review, we consider the main defined biogenesis, function, and component of secreted exosomes in different cells with a specific focus on the potential application of these exosomes as a cell-free therapeutic approach in gastrointestinal diseases like IBD, gastric cancer, and colon cancer. Additionally, exosomes role as therapeutic reagents mainly mesenchymal stem cells and dendritic cell-derived exosomes in different studies have been under intense investigation and even they are being studied in different clinical trials. Therefore, all these striking functions described for secretome implies the importance of these biocarriers.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 17
IS  - S2
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.13053
DO  - doi:10.1111/codi.13053
SP  - 38
EP  - 101
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 9
IS  - s1
SN  - 1365-182X
UR  - https://doi.org/10.1080/16515320701258846
DO  - doi:10.1080/16515320701258846
SP  - 36
EP  - 110
PY  - 2007
ER  - 

TY  - JOUR
TI  - Tuesday Posters – December 4
JO  - Respirology
VL  - 12
IS  - s4
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2007.01183.x
DO  - doi:10.1111/j.1440-1843.2007.01183.x
SP  - A195
EP  - A245
PY  - 2007
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 50
IS  - s2
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2010.02833_1.x
DO  - doi:10.1111/j.1537-2995.2010.02833_1.x
SP  - 1A
EP  - 231A
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12646
DO  - doi:10.1111/tri.12646
SP  - 22
EP  - 59
PY  - 2015
ER  - 

TY  - JOUR
TI  - ICS 2019 Gothenburg Scientific Programme
JO  - Neurourology and Urodynamics
JA  - Neurourology and Urodynamics
VL  - 38
IS  - S3
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.24118
DO  - doi:10.1002/nau.24118
SP  - S1
EP  - S532
PY  - 2019
ER  - 

TY  - JOUR
TI  - Australian Dental Research Foundation Special Research Supplement 2014
JO  - Australian Dental Journal
JA  - Aust Dent J
VL  - 59
IS  - 4
SN  - 0045-0421
UR  - https://doi.org/10.1111/adj.12231
DO  - doi:10.1111/adj.12231
SP  - S1
EP  - S44
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
VL  - 11
IS  - s1
SN  - 1462-8910
UR  - https://doi.org/10.1111/j.1463-1318.2009.01853.x
DO  - doi:10.1111/j.1463-1318.2009.01853.x
SP  - 15
EP  - 45
PY  - 2009
ER  - 

TY  - JOUR
TI  - 2019 AAPM&R Annual Assembly Abstracts
JO  - PM&R
JA  - Journal of Injury, Function and Rehabilitation
VL  - 11
IS  - S2
SN  - 1934-1482
UR  - https://doi.org/10.1002/pmrj.12271
DO  - doi:10.1002/pmrj.12271
SP  - S1
EP  - S187
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Session 1
JO  - Movement Disorders
JA  - Mov. Disord.
VL  - 21
IS  - S15
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.21246
DO  - doi:10.1002/mds.21246
SP  - S329
EP  - S424
PY  - 2006
ER  - 
